Track topics on Twitter Track topics that are important to you
Earnings reports don't get much bigger than the fiscal third-quarter report that Walgreens Boots Alliance (ticker: WBA) issued Thursday. In addition to typical market-moving information such as earnings, revenue and guidance, Walgreens finally closed the book on its two-year pursuit of Rite Aid Corp. ( RAD). Walgreens reported third-quarter adjusted diluted earnings per share of $1.33 on revenue of $30.1 billion.
Original Article: Walgreens the Clear Winner of Terminated Rite Aid DealNEXT ARTICLE
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...